Structural Formula Of Fezolinetant (Image 01)
Veozah Tablet, Film Coated
Product Images NDC 0469-2460
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Veozah (NDC 0469-2460). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Astellas Pharma Us, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Package/label Display Panel- Veozah Bottle Carton Label (Image 02)
Package/label Display Panel (VEOZAH Sample Bottle Carton Label)
Package/label Display Panel- Veozah Sampe Blister Carton (Image 04)
This is a description of the drug "VEOZAH" in tablet form with fezolinetant as its active ingredient. The recommended dosage is one tablet per day, to be taken orally and swallowed whole. Cutting, crushing, or chewing the tablets is not advisable. Each tablet contains 45g of fezolinetant. The drug must be stored at a temperature between 20°C to 25°C and must be kept out of reach of children. The manufacturer of the drug is Astelas Pharma US, Inc. The drug is not for sale. Contact 1-800-727-7003 or visit the website www.VEOZAH.com for further information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
